Genomictree Sells Colorectal Cancer Test on Malaysian Telemedicine Platform

[Asia Economy Reporter Hyungsoo Park] Genomictree, a biomarker-based in vitro diagnostics company, announced on the 19th that it has launched the EarlyTec® colorectal cancer test service through DoctorOnCall, Malaysia's largest telemedicine platform.

DoctorOnCall is the largest digital healthcare platform in Malaysia, providing medical services via phone or video calls. Genomictree is introducing the EarlyTec colorectal cancer test to offline health screening centers and hospitals through its exclusive Malaysian partner, SPD Scientific. By diversifying sales channels through DoctorOnCall and establishing a telemedicine business model, the company aims to expand its market.

In Malaysia, there is resistance to invasive tests such as colonoscopy and limitations on participation in such examinations. There is an unmet demand for in vitro diagnostic products. Since colonoscopy costs are high, the introduction of the EarlyTec® colorectal cancer test is expected to increase opportunities for colorectal cancer screening.

Genomictree is conducting various promotional activities for EarlyTec using the DoctorOnCall marketing channel. A webinar was held with Dr. Rajesh Kumar, a gastroenterology specialist from Thomson Medical Hospital Group, and Dr. Maizhuo, colorectal cancer ambassador, to emphasize the importance of early colorectal cancer diagnosis and introduce EarlyTec.

Yoon Chi-wang, Vice President of Genomictree, explained, "Southeast Asia rapidly adopted telemedicine channels due to the COVID-19 pandemic," adding, "It is experiencing high growth." He further stated, "By launching the EarlyTec® colorectal cancer test through DoctorOnCall, we will accelerate overseas market entry as a test bed for expanding Southeast Asian channels and telemedicine business models."

This content was produced with the assistance of AI translation services.